Advanced search
1 file | 1.53 MB Add to list

Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: randomised, controlled trials

(2015) VACCINE. 33(4). p.577-584
Author
Organization
Keywords
INSIGHTS, DISEASE, INFECTION, ANTIBODIES, CONJUGATE, ANTIGEN, GM-CSF, B-CELLS, STREPTOCOCCUS-PNEUMONIAE, CD4(+) T-CELLS, Vaccine, Adjuvant, Pneumonia, PhtD, Immunosenescence, Streptococcus pneumoniae

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 1.53 MB

Citation

Please use this url to cite or link to this publication:

MLA
Leroux-Roels, Isabel, et al. “Adjuvant System AS02V Enhances Humoral and Cellular Immune Responses to Pneumococcal Protein PhtD Vaccine in Healthy Young and Older Adults: Randomised, Controlled Trials.” VACCINE, vol. 33, no. 4, 2015, pp. 577–84, doi:10.1016/j.vaccine.2013.10.052.
APA
Leroux-Roels, I., Devaster, J.-M., Leroux-Roels, G., Verlant, V., Henckaerts, I., Moris, P., … Horsmans, Y. (2015). Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: randomised, controlled trials. VACCINE, 33(4), 577–584. https://doi.org/10.1016/j.vaccine.2013.10.052
Chicago author-date
Leroux-Roels, Isabel, Jeanne-Marie Devaster, Geert Leroux-Roels, Vincent Verlant, Isabelle Henckaerts, Philippe Moris, Philippe Hermand, et al. 2015. “Adjuvant System AS02V Enhances Humoral and Cellular Immune Responses to Pneumococcal Protein PhtD Vaccine in Healthy Young and Older Adults: Randomised, Controlled Trials.” VACCINE 33 (4): 577–84. https://doi.org/10.1016/j.vaccine.2013.10.052.
Chicago author-date (all authors)
Leroux-Roels, Isabel, Jeanne-Marie Devaster, Geert Leroux-Roels, Vincent Verlant, Isabelle Henckaerts, Philippe Moris, Philippe Hermand, Pascale Van Belle, Jan T Poolman, Pierre Vandepapeliére, and Yves Horsmans. 2015. “Adjuvant System AS02V Enhances Humoral and Cellular Immune Responses to Pneumococcal Protein PhtD Vaccine in Healthy Young and Older Adults: Randomised, Controlled Trials.” VACCINE 33 (4): 577–584. doi:10.1016/j.vaccine.2013.10.052.
Vancouver
1.
Leroux-Roels I, Devaster J-M, Leroux-Roels G, Verlant V, Henckaerts I, Moris P, et al. Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: randomised, controlled trials. VACCINE. 2015;33(4):577–84.
IEEE
[1]
I. Leroux-Roels et al., “Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: randomised, controlled trials,” VACCINE, vol. 33, no. 4, pp. 577–584, 2015.
@article{4345427,
  author       = {{Leroux-Roels, Isabel and Devaster, Jeanne-Marie and Leroux-Roels, Geert and Verlant, Vincent and Henckaerts, Isabelle and Moris, Philippe and Hermand, Philippe and Van Belle, Pascale and Poolman, Jan T and Vandepapeliére, Pierre and Horsmans, Yves}},
  issn         = {{0264-410X}},
  journal      = {{VACCINE}},
  keywords     = {{INSIGHTS,DISEASE,INFECTION,ANTIBODIES,CONJUGATE,ANTIGEN,GM-CSF,B-CELLS,STREPTOCOCCUS-PNEUMONIAE,CD4(+) T-CELLS,Vaccine,Adjuvant,Pneumonia,PhtD,Immunosenescence,Streptococcus pneumoniae}},
  language     = {{eng}},
  number       = {{4}},
  pages        = {{577--584}},
  title        = {{Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: randomised, controlled trials}},
  url          = {{http://doi.org/10.1016/j.vaccine.2013.10.052}},
  volume       = {{33}},
  year         = {{2015}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: